Chinese cancer therapy drawing foreign patients
Updated Mon. Sep. 25 2006 8:18 AM ET
CTV.ca News Staff
A revolutionary anti-tumour drug in China is attracting terminally ill cancer patients from around the world, including Canada.
The world’s first “gene therapy” drug, named Gendicine, was officially licensed by the Chinese government in late 2003 after clinical trials found it noticeably improved the survival rate of patients with head and neck cancer, which are common in China.


A revolutionary anti-tumour drug in China is attracting terminally ill cancer patients from around the world, including Canada.
Raquel Billiones has a PhD in Biology and has over 15 years experience as a researcher, scientific English teacher, and medical writer. Since 2006, she has been a freelance WAHM specializing in medical writing and scientific documentation. 































